Document is current
Any future updates will be listed below
-
Authors
Walsh, Zachary H.
Shah, Parin
Kothapalli, Neeharika
Shah, Shivem B. https://orcid.org/0000-0001-9439-6509
Nikolenyi, Gergo https://orcid.org/0000-0003-0581-7864
Brodtman, D. Zack https://orcid.org/0009-0009-6562-0626
Leuzzi, Giuseppe https://orcid.org/0000-0002-2211-790X
Rogava, Meri
Mu, Michael
Ho, Patricia https://orcid.org/0000-0002-4622-8188
Abuzaid, Sinan https://orcid.org/0009-0000-1629-7556
Vasan, Neil https://orcid.org/0000-0003-1779-484X
AlQuraishi, Mohammed https://orcid.org/0000-0001-6817-1322
Milner, Joshua D. https://orcid.org/0000-0002-3913-3869
Ciccia, Alberto https://orcid.org/0000-0003-4789-6564
Melms, Johannes C. https://orcid.org/0000-0002-5410-6586
Izar, Benjamin https://orcid.org/0000-0003-2379-6702
- License Information
-
More Information
Article History
Received: 1 December 2023
Accepted: 10 April 2024
First Online: 23 May 2024
Competing interests
: B.I. is a consultant for or received honoraria from Volastra Therapeutics, Johnson & Johnson (Janssen), Novartis, Eisai, AstraZeneca and Merck and has received research funding to Columbia University from Agenus, Alkermes, Arcus Biosciences, Checkmate Pharmaceuticals, Compugen, Immunocore, Regeneron and Synthekine. Z.H.W. and B.I. filed a patent application based on this work. The other authors do not have competing interests.
